Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
- PMID: 19255343
- PMCID: PMC2733238
- DOI: 10.1161/CIRCULATIONAHA.108.816082
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
Abstract
Background: Atrial fibrillation (AF) substantially increases the risk of ischemic stroke, but this risk varies among individual patients with AF. Existing risk stratification schemes have limited predictive ability. Chronic kidney disease is a major cardiovascular risk factor, but whether it independently increases the risk for ischemic stroke in persons with AF is unknown.
Methods and results: We examined how chronic kidney disease (reduced glomerular filtration rate or proteinuria) affects the risk of thromboembolism off anticoagulation in patients with AF. We estimated glomerular filtration rate using the Modification of Diet in Renal Disease equation and proteinuria from urine dipstick results found in laboratory databases. Patient characteristics, warfarin use, and thromboembolic events were ascertained from clinical databases, with validation of thromboembolism by chart review. During 33,165 person-years off anticoagulation among 10,908 patients with AF, we observed 676 incident thromboembolic events. After adjustment for known risk factors for stroke and other confounders, proteinuria increased the risk of thromboembolism by 54% (relative risk, 1.54; 95% CI, 1.29 to 1.85), and there was a graded, increased risk of stroke associated with a progressively lower level of estimated glomerular filtration rate compared with a rate > or =60 mL x min(-1) x 1.73 m(-2): relative risk of 1.16 (95% CI, 0.95 to 1.40) for estimated glomerular filtration rate of 45 to 59 mL x min(-1) x 1.73 m(-2) and 1.39 (95% CI, 1.13 to 1.71) for estimated glomerular filtration rate <45 mL x min(-1) x 1.73 m(-2) (P=0.0082 for trend).
Conclusions: Chronic kidney disease increases the risk of thromboembolism in AF independently of other risk factors. Knowing the level of kidney function and the presence of proteinuria may improve risk stratification for decision making about the use of antithrombotic therapy for stroke prevention in AF.
Figures
Comment in
-
Letter by Barrios et al regarding article, "Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study".Circulation. 2009 Nov 3;120(18):e153; author reply e154. doi: 10.1161/CIRCULATIONAHA.109.867903. Circulation. 2009. PMID: 19884478 No abstract available.
Similar articles
-
A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.Chest. 2014 Jun;145(6):1370-1382. doi: 10.1378/chest.13-2103. Chest. 2014. PMID: 24356875
-
Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.Am J Kidney Dis. 2017 Jun;69(6):734-743. doi: 10.1053/j.ajkd.2016.10.018. Epub 2016 Dec 18. Am J Kidney Dis. 2017. PMID: 27998624
-
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries.Thromb Haemost. 2017 Dec;117(12):2291-2299. doi: 10.1160/TH17-03-0198. Epub 2017 Dec 6. Thromb Haemost. 2017. PMID: 29212117
-
[Atrial fibrillation and thromboembolic events prevention. State of the art].Minerva Cardioangiol. 2001 Feb;49(1):1-13. Minerva Cardioangiol. 2001. PMID: 11279381 Review. Italian.
-
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.Contrib Nephrol. 2013;179:81-91. doi: 10.1159/000346726. Epub 2013 May 3. Contrib Nephrol. 2013. PMID: 23652451 Review.
Cited by
-
R2-CHA2DS2-VASc Score for Cardiovascular Event Prediction After Bioprosthetic Valve Replacement - Subanalysis From the BPV-AF Registry.Circ Rep. 2024 Jun 29;6(8):341-348. doi: 10.1253/circrep.CR-24-0033. eCollection 2024 Aug 9. Circ Rep. 2024. PMID: 39132334 Free PMC article.
-
Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations.Thromb Res. 2024 Sep;241:109097. doi: 10.1016/j.thromres.2024.109097. Epub 2024 Jul 23. Thromb Res. 2024. PMID: 39094333 Review.
-
Impact of renal function variability on long-term prognosis in ischemic stroke patients with atrial fibrillation.Front Neurol. 2024 Apr 22;15:1294022. doi: 10.3389/fneur.2024.1294022. eCollection 2024. Front Neurol. 2024. PMID: 38711560 Free PMC article.
-
AF-React study: Prevalence of thrombotic events in patients with atrial fibrillation receiving NOACs - real-world data analysis from northern Portugal primary healthcare.Front Med (Lausanne). 2024 Apr 12;11:1273304. doi: 10.3389/fmed.2024.1273304. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38681055 Free PMC article.
-
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals (Basel). 2024 Mar 26;17(4):418. doi: 10.3390/ph17040418. Pharmaceuticals (Basel). 2024. PMID: 38675379 Free PMC article. Review.
References
-
- Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375. - PubMed
-
- Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469–473. - PubMed
-
- Wolf P, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–988. - PubMed
-
- Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:429S–456S. - PubMed
-
- Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, Selby JV, Singer DE. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation. 2000;102:11–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
